中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2013年
19期
20-21
,共2页
糖尿病%高血脂症%六味地黄丸
糖尿病%高血脂癥%六味地黃汍
당뇨병%고혈지증%륙미지황환
Diabetes%Hyperglycemia%The Liuwei Dihuang pill
目的:探讨六味地黄丸对2型糖尿病合并有高脂血症患者的疗效。方法:将我院86例2型糖尿病并有高脂血症患者随机分为治疗组及对照组,治疗组在常规治疗基础上加用六味地黄丸(重庆中药二厂生产),9g/次,2次/d,治疗3个月后,研究血糖,血脂和血清高敏C反应蛋白(hs-CRP)的变化,临床预后等影响,并记录服药期内患者出现的不适症状。结果:治疗组与对照组比较,治疗后血脂,血糖等指标明显下降,明显改善患者的远期预后,明显降低患者再住院率;其总有效率明显改善有统计学意义,(27.9%vs 18.6%,P<0.05)。结论:在西医治疗基础上加用六味地黄丸可降低血脂、血糖水平、减少心脑血管意外事件的发生,值得临床推广。
目的:探討六味地黃汍對2型糖尿病閤併有高脂血癥患者的療效。方法:將我院86例2型糖尿病併有高脂血癥患者隨機分為治療組及對照組,治療組在常規治療基礎上加用六味地黃汍(重慶中藥二廠生產),9g/次,2次/d,治療3箇月後,研究血糖,血脂和血清高敏C反應蛋白(hs-CRP)的變化,臨床預後等影響,併記錄服藥期內患者齣現的不適癥狀。結果:治療組與對照組比較,治療後血脂,血糖等指標明顯下降,明顯改善患者的遠期預後,明顯降低患者再住院率;其總有效率明顯改善有統計學意義,(27.9%vs 18.6%,P<0.05)。結論:在西醫治療基礎上加用六味地黃汍可降低血脂、血糖水平、減少心腦血管意外事件的髮生,值得臨床推廣。
목적:탐토륙미지황환대2형당뇨병합병유고지혈증환자적료효。방법:장아원86례2형당뇨병병유고지혈증환자수궤분위치료조급대조조,치료조재상규치료기출상가용륙미지황환(중경중약이엄생산),9g/차,2차/d,치료3개월후,연구혈당,혈지화혈청고민C반응단백(hs-CRP)적변화,림상예후등영향,병기록복약기내환자출현적불괄증상。결과:치료조여대조조비교,치료후혈지,혈당등지표명현하강,명현개선환자적원기예후,명현강저환자재주원솔;기총유효솔명현개선유통계학의의,(27.9%vs 18.6%,P<0.05)。결론:재서의치료기출상가용륙미지황환가강저혈지、혈당수평、감소심뇌혈관의외사건적발생,치득림상추엄。
Objective:To observe the clinical efficacy of the Liuwei Dihuang pill in the treatment of diabetes and hyperlipidemia. Methods:86 cases of diabetes and hyperlipidemia patients were randomly divided into the treated group and control group, the treatment group take the Liuwei Dihuang pill, 9g each time, 2 times a day, on the basis of the conventional treatment. After the treatment for 3 months, follow up the Blood sugar, blood lipid and serum high-sensitivity c-reactive protein (hs-CRP). Results:After 3 months treatment, treated group compared with the control group, blood sugar, blood lipid and serum high-sensitivity c-reactive protein was significantly improved;significantly reduced hospitalization rates again; The total efficiency obviously was improved (27.9% vs 18.6%), the two groups had statistically significant (P<0.05). Conclusion: Treated group on the basic treatment of modern medicine, the Liuwei Dihuang pill can decrease blood lipids level, reduce cerebrovascular accident, worthy the clinical promotion.